Home > Press > NaturalNano Adds Chief Engineer and Polymer Research Director
Industry Veterans Bring Decades of Experience in Nanotechnology
NaturalNano Adds Chief Engineer and Polymer Research Director
Rochester, NY | Posted on August 28th, 2007
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) (www.naturalnano.com), a developer of advanced nanocomposite materials and additive technologies, today announced the expansion of its growing roster of top-tier talent with the addition of two nanotechnology veterans.
Dr. Robert Daly joins NaturalNano as Polymer Research Director and Dr. Douglas Kelley joins as Chief Engineer. Both individuals are based at NaturalNano's corporate headquarters and research lab in Rochester, NY, where the Company anchors the University of Rochester's new Bio-Enterprise research center.
"We are fortunate to be in a position to attract such celebrated industry talent as we continue to focus on growing our business and accelerate our march toward product commercialization," said Cathy Fleischer, Ph.D., President and Chief Technology Officer of NaturalNano. "The additions of Dr. Daly and Dr. Kelley are critical elements as we continue to create and exploit nanocomposite technologies. Equally important, these are both newly created positions that speak to our progress and expanding opportunity."
Dr. Daly is concentrating his work on end-market applications and surface treatments of NaturalNano's proprietary turn-key additive, Pleximer™. He joins NaturalNano from Eastman Kodak, one of the world's leading nanotechnology patent holders, where he served as unit director for Kodak's Global Manufacturing Technology Organization. Daly holds 16 U.S. patents in the polymer field and brings more than 30 years of experience in a variety of science, research and product development positions. He holds a bachelor of science in chemistry from the University of Kansas and a Ph.D. from the University of Arizona in Polymer Science.
Dr. Kelley is focused on the continued development of process applications for Pleximer, with an eye toward future uses such as filled tube applications. He has over 25 years' experience in process development and polymer extrusion; most recently Dr. Kelley led the ESTAR™ Process Group that was responsible for reducing waste and improving productivity in manufacturing processes. Kelley holds a master's in mechanical and aerospace engineering from Cornell University and a Ph.D. in chemical engineering from the University of Rochester.
"Many things attracted us to NaturalNano, but two really stand out in my mind," Daly said. "The first is the potential inherent in Pleximer and its numerous market-changing applications. The second is the number of talented researchers and industry minds that have signed on to help NaturalNano realize its goal of industry leadership."
Kelley added, "The ability to work with this team and on a project that has nearly limitless potential is what brought me to NaturalNano. I believe we are well positioned to leverage our technological advances, particularly in the little explored, but seemingly superior Halloysite nanotube (HNT™) sector of the nanocomposite market."
NaturalNano said it continues to execute on its development timeline for the Pleximer product and remains on the path toward initial commercialized product by year-end 2007. NaturalNano is working with its joint development partners to test and validate its Pleximer product for a number of industrial and consumer product applications. Pleximer is a Halloysite concentrate for polymers that makes them stronger and lighter, yet less expensive to process than other nanocomposite materials.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposite materials. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer™ polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. For more information, visit http://www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
For more information, please click here
Jeff Lambert or Patrick Kane
Lambert, Edwards & Associate
Copyright © Market Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Thinnest feasible membrane produced April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014
Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014
Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014